Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Step by step instructions to Pick the Ideal Authorize Internet Advertising Degree Program - 2Sunken warship found off Danish coast after 225 years in ‘remarkable’ discovery
- 3America's Confided in Cooler in 2024
- 4Most loved Web-based feature: Which Stage Do You Like
- 5NMG signs new graphite supply deal with Canadian Government
- New studies of old dogs help scientists understand where they came from
- Exploring ways to reduce the impact of space junk on Earth
- Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered.
- Barn Stored Lotus Esprit Turbo Seen After 30 Years
- The cheap health insurance promoted by Trump officials has this catch
- Viable Correspondence: Building Solid Connections
- Artemis II astronauts are more than halfway to the moon as they seek to break Apollo 13's record
- The 12 biggest space stories of 2025 — according to you
- How to watch ‘The Traitors’ Season 4: Premiere date, episode release time, full cast list and more
